PRA Health Sciences (PRAH) Reports Q4 EPS of $1.55

PRA Health Sciences (NASDAQ: PRAH) reported Q4 EPS of $1.55, versus $1.54 reported last year. Revenue for the quarter came in at $873.5 million, versus $800.2 million reported last year.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• BlackRock’s Rosenberg says inflation data key after jobs beat
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'